The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆-Reference-Cited by-同舟云学术

The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆

Published:2011-01 Issue:1 Volume:43 Page:1-20
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Orlando Ambrogio,Armuzzi Alessandro,Papi Claudio,Annese Vito,Ardizzone Sandro,Biancone Livia,Bortoli Aurora,Castiglione Fabiana,D’Incà Renata,Gionchetti Paolo

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s disease;Inflammation Research;2024-01-02

2. Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting;Digestive and Liver Disease;2024-01

3. Complementary and alternative medicine mention and recommendations in inflammatory bowel disease guidelines: systematic review and assessment using AGREE II;BMC Complementary Medicine and Therapies;2023-07-11

4. Editorial: Abdominal and Perianal Fistulizing Crohn's Disease: Imaging, Surgical Techniques and Basic Research;Frontiers in Surgery;2022-06-28

5. Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology;Digestive and Liver Disease;2022-04